ALMU (NASDAQ: ALMU) resale filing shows two 10b5-1 sales totaling 40,000 shares

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 disclosing proposed resale of 40,000 shares of Common Stock identified as Founders Shares with an original issuance date of 10/27/2020. The excerpt lists two 10b5-1 sales by Jonathan Klamkin: 20,000 shares sold on 06/01/2026 for $500,662 and 20,000 shares sold on 05/01/2026 for $499,242.

Insights

Corporate Governance Analyst

Form 144 lists resale activity under a 10b5-1 plan and a 40,000-share resale filing.

The filing names Founders Shares totaling 40,000 shares to be sold and documents two prior 10b5-1 transactions by Jonathan Klamkin on 05/01/2026 and 06/01/2026

Cash‑flow treatment is not specified beyond the reported sale proceeds; subsequent disclosures may provide additional context regarding the remaining shares or distribution method.

Key Figures

Shares to be sold: 40,000 shares Sale on 05/01/2026: 20,000 shares Sale on 06/01/2026: 20,000 shares +1 more

4 metrics

Shares to be sold 40,000 shares Founders Shares; issuance date 10/27/2020

Sale on 05/01/2026 20,000 shares Proceeds reported $499,242

Sale on 06/01/2026 20,000 shares Proceeds reported $500,662

Issuance date 10/27/2020 Founders Shares original issuance date

Key Terms

Form 144, 10b5-1, Founders Shares

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for JONATHAN KLAMKIN"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Founders Shares financial

"Common | 10/27/2020 | Founders Shares"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/01/2026 - 05:02 PM Accepted by SEC EDGAR 07/01/2026 - 05:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	40000	883200.00	18305335	07/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/27/2020	Founders Shares	Issuer			40000	10/27/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JONATHAN KLAMKIN 27 Castilian Drive Goleta CA 93117	Common	06/01/2026	20000	500662.00
10b5-1 Sales for JONATHAN KLAMKIN 27 Castilian Drive Goleta CA 93117	Common	05/01/2026	20000	499242.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ALMU's Form 144 disclose about the shares being sold?

The Form 144 discloses a proposed resale of 40,000 shares of Common Stock labeled as Founders Shares with an issuance date of 10/27/2020. The filing lists prior 10b5-1 sales by the reporting person.

Who executed the recent 10b5-1 sales reported in the ALMU excerpt?

The excerpt shows 10b5-1 sales executed by Jonathan Klamkin. It lists sales of 20,000 shares on 05/01/2026 and 20,000 shares on 06/01/2026.

How much proceeds were reported for the 10b5-1 sales in the filing?

The filing reports proceeds of $499,242 for the 05/01/2026 sale and $500,662 for the 06/01/2026 sale, each corresponding to 20,000 shares.

Does the excerpt state whether the company receives proceeds from these sales?

The excerpt lists resale transactions and sale proceeds tied to the reporting person; it does not state that the issuer receives any proceeds from these reported resales.

Are the listed sales described as part of a 10b5-1 plan in the ALMU excerpt?

Yes. Each sale in the excerpt is labeled as a 10b5-1 Sale, indicating the transactions were executed under a prearranged trading plan as described in the filing text.